Association of IL10 promoter polymorphisms with idiopathic achalasia

Human Immunology

Volumn 72, Issue 9, 2011, Pages 749-752

  Nuñez, Concepción ^a   García González, María Asunción ^b,c   Santiago, Jose Luis ^a   Benito, María Soledad ^a   Mearín, Fermín ^d   de la Concha, Emilio G ^a   Pérez de la Serna, Julio ^a   Ruiz de León, Antonio ^a   Urcelay, Elena ^a   Vigo, Ana G ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d CENTRO MÉDICO TEKNON   (Spain)

Author keywords

Disease susceptibility; Idiopathic achalasia; Single nucleotide polymorphism

Indexed keywords

HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; INTERLEUKIN 10;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ESOPHAGUS ACHALASIA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; ESOPHAGEAL ACHALASIA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; IMMUNITY; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SPAIN;

EID: 84860401792     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.05.017     Document Type: Article

References (39)

1. Mearin F., Mourelle M., Guarner F., Salas A., Riveros-Moreno V., Moncada S., et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest 1993, 23:724-728.
2. Clark S.B., Rice T.W., Tubbs R.R., Richter J.E., Goldblum J.R. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol 2000, 24:1153-1158.
3. Raymond L., Lach B., Shamji F.M. Inflammatory aetiology of primary oesophageal achalasia: an immunohistochemical and ultrastructural study of Auerbach's plexus. Histopathology 1999, 35:445-453.
4. Moses P.L., Ellis L.M., Anees M.R., Ho W., Rothstein R.I., Meddings J.B., et al. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut 2003, 52:629-636.
5. Storch W.B., Eckardt V.F., Wienbeck M., Eberl T., Auer P.G., Hecker A., et al. Autoantibodies to Auerbach's plexus in achalasia. Cell Mol Biol Noisy-le-grand 1995, 41:1033-1038.
6. Verne G.N., Hahn A.B., Pineau B.C., Hoffman B.J., Wojciechowski B.W., Wu W.C. Association of HLA-DR and -DQ alleles with idiopathic achalasia. Gastroenterology 1999, 117:26-31.
7. de la Concha E.G., Fernandez-Arquero M., Conejero L., Lazaro F., Mendoza J.L., Sevilla M.C., et al. Presence of a protective allele for achalasia on the central region of the major histocompatibility complex. Tissue Antigens 2000, 56:149-153.
8. De la Concha E.G., Fernandez-Arquero M., Mendoza J.L., Conejero L., Figueredo M.A., Perez de la Serna J., et al. Contribution of HLA class II genes to susceptibility in achalasia. Tissue Antigens 1998, 52:381-384.
9. Wong R.K., Maydonovitch C.L., Metz S.J., Baker J.R. Significant DQw1 association in achalasia. Dig Dis Sci 1989, 34:349-352.
10. Park W., Vaezi M.F. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol 2005, 100:1404-1414.
11. Di Nardo G., Tullio-Pelet A., Annese V., Stanghellini V., Barbara G., Latiano A., et al. Idiopathic achalasia is not allelic to alacrima achalasia adrenal insufficiency syndrome at the ALADIN locus. Dig Liver Dis 2005, 37:312-315.
12. Mearin F., García-González M.A., Strunk M., Zárate N., Malagelada J.R., Lanas A., et al. Association between achalasia and nitric oxide synthase gene polymorphisms. Am J Gastroenterol 2006, 101:1979-1984.
13. Vigo A.G., Martínez A., de la Concha E.G., Urcelay E., Ruiz de León A. Suggested association of NOS2A polymorphism in idiopathic achalasia: no evidence in a large case-control study. Am J Gastroenterol 2009, 104:1326-1327.
14. Santiago J.L., Martínez A., Benito M.S., Ruiz de León A., Mendoza J.L., Fernández-Arquero M., et al. Gender-specific association of the PTPN22 C1858T polymorphism with achalasia. Hum Immunol 2007, 68:867-870.
15. Paladini F., Cocco E., Cascino I., Belfiore F., Badiali D., Piretta L., et al. Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene. Neurogastroenterol Motil 2009, 21:597-602.
16. de León A.R., de la Serna J.P., Santiago J.L., Sevilla C., Fernández-Arquero M., de la Concha E.G., et al. Association between idiopathic achalasia and IL23R gene. Neurogastroenterol Motil 2010, 22:734-738.
17. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463.
18. Einarsdottir E., Koskinen L.L., Dukes E., Kainu K., Suomela S., Lappalainen M., et al. IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. BMC Med Genet 2009, 10:8.
19. Gateva V., Sandling J.K., Hom G., Taylor K.E., Chung S.A., Sun X., et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009, 41:1228-1233.
20. Suarez A., Lopez P., Mozo L., Gutierrez C. Differential effect of IL10 and TNFα genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis 2005, 64:1605-1610.
21. Barrett J.C., Clayton D.G., Concannon P., Akolkar B., Cooper J.D., Erlich H.A., et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009, 41:703-707.
22. Franke A., Balschun T., Karlsen T.H., Sventoraityte J., Nikolaus S., Mayr G., et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008, 40:1319-1323.
23. Lim S., Crawley E., Woo P., Barnes P.J. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 1998, 352:113.
24. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010, 10:170-181.
25. Westendorp R.G., Langermans J.A., Huizinga T.W., Elouali A.H., Verweij C.L., Boomsma D.I., et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997, 349:170-173.
26. Eskdale J., Kube D., Tesch H., Gallagher G. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics 1997, 46:120-128.
27. Giordani L., Bruzzi P., Lasalandra C., Quaranta M., Schittulli F., Della Ragione F., et al. Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes. Clin Chem 2003, 49:1664-1667.
28. Claudino M., Trombone A.P., Cardoso C.R., Ferreira S.B., Martins W., Assis G.F., et al. The broad effects of the functional IL-10 promoter-592 polymorphism: modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome. J Leukoc Biol 2008, 84:1565-1573.
29. Crawley E., Kay R., Sillibourne J., Patel P., Hutchinson I., Woo P. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999, 42:1101-1108.
30. Steinke J.W., Barekzi E., Hagman J., Borish L. Functional analysis of -571 IL-10 promoter polymorphism reveals a repressor element controlled by sp1. J Immunol 2004, 173:3215-3222.
31. Suárez A., Castro P., Alonso R., Mozo L., Gutiérrez C. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 2003, 75:711-717.
32. Rad R., Dossumbekova A., Neu B., Lang R., Bauer S., Saur D., et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004, 53:1082-1089.
33. Ruiz-de-León A., Mendoza J., Sevilla-Mantilla C., Fernández A.M., Pérez-de-la-Serna J., Gónzalez V.A., et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci 2002, 47:15-19.
34. Smith A.J., Humphries S.E. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009, 20:43-59.
35. Goldblum J.R., Rice T.W., Richter J.E. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996, 111:648-654.
36. Facco M., Brun P., Baesso I., Costantini M., Rizzetto C., Berto A., et al. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol 2008, 103:1598-1609.
37. Kilic A., Owens S.R., Pennathur A., Luketich J.D., Landreneau R.J., Schuchert M.J., et al. An increased proportion of inflammatory cells express tumor necrosis factor alpha in idiopathic achalasia of the esophagus. Dis Esophagus 2009, 22:382-385.
38. Griffin W.S. Inflammation and neurodegenerative diseases. Am J Clin Nutr 2006, 83:470S-474S.
39. Bruley des Varannes S., Chevalier J., Pimont S., Le Neel J.C., Klotz M., Schafer K.H., et al. Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus. Gut 2006, 55:319-326.